http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2618825-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46c4a47148c490f49b7c3fb59f4ccc9c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2c8bd100273ffd74d1d741bf4ed0a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e7cc94ba615b8c0a03f2d16bc0d03e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af610dcbf685bd887dc02649e5f341b7
publicationDate 2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2618825-A4
titleOfInvention USE OF NIGERICIN FOR THE TREATMENT AND PREVENTION OF VACCINE VIRUS INFECTIONS
priorityDate 2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2836289-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0294538-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226515076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551229

Total number of triples: 20.